Viking Therapeutics Announces Strong Second Quarter 2025 Financial Performance and Provides Key Corporate Updates,PR Newswire Healthring
Here’s a detailed article about Viking Therapeutics’ Q2 2025 financial results and corporate update, presented in a polite and informative tone: Viking Therapeutics Announces Strong Second Quarter 2025 Financial Performance and Provides Key Corporate Updates San Diego, CA – July 23, 2025 – Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on developing … Read more